Patents by Inventor Michael LEWANDOWSKI

Michael LEWANDOWSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076875
    Abstract: A shingle coating asphalt composition is provided that is produced from a paving grade asphalt. The asphalt composition comprises a paving-grade asphalt that has been modified with one or more polymer additives; and a secondary additive comprising one or more of a viscosity reducing agent, a wax, a salt of a fatty acid ester, and an amide of a fatty acid. The shingle coating asphalt coating composition is used to make a shingle. The shingle includes a substrate, the asphalt, and roofing granules.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Inventors: Carmen Anthony LaTorre, Jacob Paul Honsvick, Christopher Patrick Kasprzak, Daniel James Buckwalter, Edward R. Harrington, Jonathan Ross Davis, Laurand Henry Lewandowski, David Michael Ploense, William Edwin Smith, Scott W. Schweiger, Ganesh Latta
  • Publication number: 20160184322
    Abstract: The present invention relates to prophylactic and post-acute treatments of mild TBI (including concussions).
    Type: Application
    Filed: October 26, 2015
    Publication date: June 30, 2016
    Inventors: Jacob W. Vanlandingham, John Suber, Vedrana Marin, Michael Lewandowski, Nicholas Dey
  • Patent number: 8492368
    Abstract: Compositions and methods for treating traumatic brain injury (TBI) and mild traumatic brain injury (mTBI) using progesterone and ent-progesterone are described.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: July 23, 2013
    Assignee: Florida State University Research Foundation
    Inventors: Jacob W. Vanlandingham, John Suber, Michael Lewandowski
  • Publication number: 20130090316
    Abstract: Compositions and methods for treating traumatic brain injury (TBI) and mild traumatic brain injury (mTBI) using progesterone and ent-progesterone are described.
    Type: Application
    Filed: October 5, 2012
    Publication date: April 11, 2013
    Applicant: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Jacob W. VANLANDINGHAM, John SUBER, Vedrana MARIN, Michael LEWANDOWSKI
  • Publication number: 20130090317
    Abstract: Compositions and methods for treating traumatic brain injury (TBI) and mild traumatic brain injury (mTBI) using progesterone and ent-progesterone are described.
    Type: Application
    Filed: October 5, 2012
    Publication date: April 11, 2013
    Applicant: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Jacob W. VANLANDINGHAM, John SUBER, Vedrana MARIN, Michael LEWANDOWSKI
  • Patent number: 6566508
    Abstract: Disclosed are novel coumarin based fluorogenic compounds useful in assaying for biological activity. Specifically, these fluorogenic compounds exhibit fluorescence at particular wavelengths when cleaved by target enzymes. Preferred compounds include sugar and peptide derivatives of umbelliferone derivatives bearing a heterocyclic five membered ring at the 3-position. These compounds can be used for rapidly detecting food pathogens and for determining sterilization effectiveness. The compounds may also be used in a form bounded to a polymeric support or to a biomolecule or macromolecule.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: May 20, 2003
    Assignee: 3M Innovative Properties Company
    Inventors: James Gregory Bentsen, Christopher Allen Mickelson, Orlin Bruce Knudson, Kevin Michael Lewandowski
  • Publication number: 20020147317
    Abstract: Disclosed are novel coumarin based fluorogenic compounds useful in assaying for biological activity. Specifically, these fluorogenic compounds exhibit fluorescence at particular wavelengths when cleaved by target enzymes. Preferred compounds include sugar and peptide derivatives of umbelliferone derivatives bearing a heterocyclic five membered ring at the 3-position. These compounds can be used for rapidly detecting food pathogens and for determining sterilization effectiveness. The compounds may also be used in a form bounded to a polymeric support or to a biomolecule or macromolecule.
    Type: Application
    Filed: March 11, 2002
    Publication date: October 10, 2002
    Applicant: 3M Innovative Propeties Company
    Inventors: James Gregory Bentsen, Christopher Allen Mickelson, Orlin Bruce Knudson, Kevin Michael Lewandowski
  • Patent number: 6372895
    Abstract: Disclosed are novel coumarin based fluorogenic compounds useful in assaying for biological activity. Specifically, these fluorogenic compounds exhibit fluorescence at particular wavelengths when cleaved by target enzymes. Preferred compounds include sugar and peptide derivatives of umbelliferone derivatives bearing a heterocyclic five membered ring at the 3-position. These compounds can be used for rapidly detecting food pathogens and for determining sterilization effectiveness. The compounds may also be used in a form bounded to a polymeric support or to a biomolecule or macromolecule.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: April 16, 2002
    Assignee: 3M Innovative Properties Company
    Inventors: James Gregory Bentsen, Christopher Allen Mickelson, Orlin Bruce Knudson, Kevin Michael Lewandowski